Humacyte (HUMA) Current Leases (2020 - 2026)
Humacyte (HUMA) posted quarterly Current Leases of $2.4 million for Q1 2026, down 19.23% year-over-year from $3.0 million in Q1 2025, and little changed quarter-over-quarter from $2.4 million in Q4 2025.
Humacyte (HUMA) Current Leases (2020 - 2026) Analysis & Trends
Humacyte (HUMA) has reported Current Leases for 7 consecutive years, with $2.4 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Leases fell 19.23% year-over-year to $2.4 million; the TTM figure through Mar 2026 stood at $2.4 million (down 19.23% YoY), while the FY2025 annual figure was $2.4 million, down 16.76% from the prior year.
- Current Leases held at $2.4 million in Q1 2026 per HUMA's latest filing, from $2.4 million in the prior quarter.
- Across five years, Current Leases topped out at $3.1 million in Q2 2025 and bottomed at $46000.0 in Q1 2022.
- Historically, Current Leases has averaged $1.8 million across 5 years, with a median of $2.4 million in 2025.
- Annual changes were most pronounced in 2023 — Current Leases slumped 97.62% — and 2024, when it jumped 5284.31%.
- Humacyte's Current Leases stood at $50000.0 in 2022, then jumped by 5020.0% to $2.6 million in 2023, then grew by 13.95% to $2.9 million in 2024, then declined by 16.76% to $2.4 million in 2025, then changed by 0.0% to $2.4 million in 2026.
- Business Quant data shows HUMA's Current Leases at $2.4 million in Q1 2026, $2.4 million in Q4 2025, and $2.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Humacyte | 158.12 Mn | 158.12 Mn | -825,000.00 | 1.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Mn |
| Mar 31, 2026 | 2.43 Mn |
| Dec 31, 2025 | 2.43 Mn |
| Sep 30, 2025 | 2.67 Mn |
| Jun 30, 2025 | 3.09 Mn |
| Mar 31, 2025 | 3.01 Mn |
| Dec 31, 2024 | 2.92 Mn |
| Sep 30, 2024 | 57,000.00 |
| Jun 30, 2024 | 2.75 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.56 Mn |
| Sep 30, 2023 | 52,000.00 |
| Jun 30, 2023 | 51,000.00 |
| Mar 31, 2023 | 2.33 Mn |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 2.19 Mn |
| Jun 30, 2022 | 2.12 Mn |
| Mar 31, 2022 | 46,000.00 |
| Dec 31, 2021 | 1.98 Mn |
| Sep 30, 2021 | 1.92 Mn |